The Story
ā¢Ā Composition and format
a-Klotho MAB or Ī±-Klotho MAB (10 mcg) is a monoclonal antibody directed against the a-Klotho protein and is supplied as 10 mcg per vial for controlled laboratory workflows. The batch-specific Certificate of Analysis (COA) details antigen target information, format, and buffer or lyophilized state, supporting method-level reproducibility and documentation control.
ā¢ Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
ā¢ Intended research use
a-Klotho MAB is evaluated in controlled in-vitro systems interrogating a-Klotho-associated signaling, including insulin, Wnt, and FGF23 pathways, as well as cell-matrix communication and pathway mapping. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes.
ā¢ Research characteristics and applications
This monoclonal antibody is validated for affinity and specificity to the a-Klotho protein. It is applied in analytical and cell-based models to study Klotho-associated signaling, including FGF23, Wnt, and insulin-related pathways. Researchers employ this antibody to examine proteināprotein interactions and downstream molecular feedback loops relevant to cellular metabolism and systemic regulatory mechanisms.
ā¢ Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
Description
ā¢Ā Composition and format
a-Klotho MAB or Ī±-Klotho MAB (10 mcg) is a monoclonal antibody directed against the a-Klotho protein and is supplied as 10 mcg per vial for controlled laboratory workflows. The batch-specific Certificate of Analysis (COA) details antigen target information, format, and buffer or lyophilized state, supporting method-level reproducibility and documentation control.
ā¢ Analytical verification
Each lot is qualified at 99%+ purity by high-performance liquid chromatography; identity is confirmed by mass spectrometry; and independent third-party laboratories corroborate in-house analytics to maintain traceable quality metrics appropriate for research use.
ā¢ Intended research use
a-Klotho MAB is evaluated in controlled in-vitro systems interrogating a-Klotho-associated signaling, including insulin, Wnt, and FGF23 pathways, as well as cell-matrix communication and pathway mapping. All technical communications are method-centric and do not imply diagnostic, therapeutic, performance, or clinical outcomes.
ā¢ Research characteristics and applications
This monoclonal antibody is validated for affinity and specificity to the a-Klotho protein. It is applied in analytical and cell-based models to study Klotho-associated signaling, including FGF23, Wnt, and insulin-related pathways. Researchers employ this antibody to examine proteināprotein interactions and downstream molecular feedback loops relevant to cellular metabolism and systemic regulatory mechanisms.
ā¢ Manufacturing and documentation
Alpha BioMed Labs manufactures this material in the United States under defined quality procedures and research-only labeling. COAs, raw-material provenance from vetted suppliers, and batch records are maintained to facilitate institutional procurement review and audit readiness.
